Who invested in Accolade

9 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$236Mraised across 9 rounds since 2007, from 9 sources

$20MSeries A$4.0MDebt$17MSeries B$30MSeries D$2.8MVenture$23MSeries E$70MSeries E$50MRound$20MRound

Latest round: Round, $20MOct 2019
Biggest round: $70MSeries E · Aug 2016
Investors: 11

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2007200920112013201520172019

$20MSeries A$4.0MDebt$17MSeries B$30MSeries D$2.8MVenture$23MSeries E$70MSeries E$50MRound$20MRound

First round: Series A, $20M
Biggest round: $70M
Usual gap between rounds: 18 months

The rounds

Oct 2019
Round$20M1 new
- Humana
Reported by AccoladeSEC filing: $20M sold, first sale Oct 2019
Mar 2018
Round$50M3 new2 returning
- Andreessen Horowitz
- Madrona Venture Group
- Carrick Capital Partners
- Madera
- McKesson Ventures/ Cross Creek
Reported by FinSMEsSEC filing: $27M sold, first sale Mar 2018
Aug 2016
Series E$70M1 new
- Andreessen Horowitz
Reported by FinSMEsSEC filing: $55M sold, first sale Jul 2016
Jul 2015
Series E$23M2 new
- McKesson Ventures
- Independence Health Group
From a historical funding recordSEC filing: $23M sold, first sale Jul 2015
May 2014
Venture$2.8M
No investor was named in the report.
From a historical funding recordSEC filing: $2.8M sold, first sale Apr 2014
Dec 2013
Series D$30M1 new2 returning
From a historical funding recordSEC filing: $30M sold, first sale Dec 2013
Jun 2010
Series B$17M2 new1 returning
From a historical funding recordSEC filing: $17M sold, first sale Jun 2010
Jan 2010
Debt$4.0M
No investor was named in the report.
Reported by sec.govSEC filing: $4.0M sold, first sale Oct 2009
Feb 2007
Series A$20M1 new
- Accretive LLC
From a historical funding record

Founders and team

From Accolade's own website and the SEC filings it signed: 8 on the team.

Anthy KoutsoudakisAssistant General Manager
Maria LeaderPA to director
Shirley NakaniPA to the Director
Verity GrangerGeneral Manager
Michael J. HiltonExecutive Officeri
Rajeev J. SinghExecutive Officer, Directori
Robert J. CavanaughExecutive Officeri
Stephen J. BarnesExecutive Officeri

On the board, as filediCindy KentDawn J. LeporeElizabeth J. NabelJeff J. JordanJeffrey BrodskyPatricia J. WadorsPeter KleinThomas J. Neff

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Debt2010Series B2010Series D2013Venture2014Series E2015Series E2016Round2018Round2019

Andreessen Horowitz

Comcast Ventures

Carrick Capital Partners

Oak Hill Capital Management, LLC

Accretive LLC

Madrona Venture Group

McKesson Ventures

HumanaIndependence Health GroupMadera

Everyone who backed them

Andreessen HorowitzVC firm2rounds

Comcast VenturesCorporate VC2rounds

Carrick Capital PartnersPrivate equity2rounds

Oak Hill Capital Management, LLCVC firm2rounds

Accretive LLCPrivate equity2rounds

Madrona Venture GroupVC firm1round

McKesson VenturesGrowth equity1round

HumanaCorporate VC1round

Independence Health Groupno record of our own yet1round

Maderano record of our own yet1round

McKesson Ventures/ Cross Creekno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Accolade as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Cross CreekVC firmPer its own site

Escalate CapitalPrivate creditPer its own site

Quick answers about Accolade

Who invested in Accolade?

Accolade's investors include Andreessen Horowitz, Comcast Ventures, Carrick Capital Partners, Oak Hill Capital Management, LLC and Accretive LLC, and 6 more on record.